U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX21412512: GSM7717594: 4T1, Day4, single cell 18; Mus musculus; RNA-Seq
1 ILLUMINA (HiSeq X Ten) run: 6M spots, 1.8G bases, 698.6Mb downloads

External Id: GSM7717594_r1
Submitted by: Tsinghua University
Study: Characterizing the gene expression profiles of 4T1 and 4T1.2 cells at different stages of bone metastsis using SMART-Seq2 technology
show Abstracthide Abstract
Bone metastasis, a frequent and devastating occurrence in breast cancer, affects over 70% of patients over time. Intriguingly, cancer cells residing within the bone microenvironment can serve as "cancer seeds," disseminating to distant organs and driving extensive metastasis. Even post-successful primary tumor removal, quiescent cells can persist, contributing to bone recurrence. This phenomenon underscores the remarkably low efficiency of bone metastasis establishment and underscores the significance of comprehending the molecular underpinnings of this early bone-seeding phase. Deciphering the mechanisms orchestrating tumor cell dormancy and reawakening holds pivotal implications for designing effective anti-cancer therapies. Dormant tumor cells within the bone might be likened to being ensnared in an "extended seeding phase" prior to eventual expansion. Conceivably, shared signaling molecules could govern both proficient bone metastatic colonization and the re-emergence of indolent metastatic cells. Consequently, the molecular facilitators enabling bone colonization could also be integral to the reactivation of dormant tumor cells within the bone milieu. In this study, we conducted single-cell RNA sequencing (scRNA-seq) analysis on tumor cells procured from the initial stages of bone colonization within experimental bone metastasis models. Our investigation unearthed potential factors that foster tumor cell survival during this critical seeding phase. Overall design: Female BALB/c mice were subjected to intracardiac (IC) injections of 4T1 and 4T1.2 cells labeled with Firefly-luciferase and mCherry. At various time points, including Day 4 (early seeding phase, D4), Day 10 (progression phase, D10), and Day 16 (late-stage bone metastasis phase, D16), a subset of mice were sacrificed to recover metastatic tumor cells from the hindlimbs. The mCherry+ tumor cells were subsequently isolated using fluorescence-activated cell sorting (FACS). Utilizing single-cell cDNA amplification and next-generation sequencing (NGS) library construction, we conducted comprehensive analysis. Furthermore, we isolated in vitro cultured cells and primary tumor cells injected into the mammary fat pad to generate supplementary scRNA-seq data, serving as additional controls for our study.
Sample: 4T1, Day4, single cell 18
SAMN37046578 • SRS18650990 • All experiments • All runs
Organism: Mus musculus
Library:
Name: GSM7717594
Instrument: HiSeq X Ten
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC SINGLE CELL
Selection: cDNA
Layout: PAIRED
Construction protocol: Reverse transcription and cDNA amplification were carried out using a modified Smart-seq2 protocol (Picelli et al., 2014). Single cells were sorted by FACS as described above into 96-well plates containing 0.1 μl of RNase inhibitor (Clontech, Cat# 2313A), 1.9 μl of 0.2% Triton X-100 (Sigma, Cat# T9284), 1 μl of 10 µM oligo-dT primer (5′-AAGCAGTGGTATCA ACGCAGAGTAC T30VN-3′) and 1 μl of dNTP mix (10 mM each; Fermentas, Cat# R0192) in each well. Plates were either stored at -80 °C or processed immediately. Reverse transcription, PCR preamplification, PCR purification were performed following Picelli's protocol (Picelli et al., 2014). As mRNA quality control, 1 ul of each PCR product was used as template for qPCR detection of mCherry expression and samples with Ct value higher than 30 will be discard. PCR products were purified with 1 × Agencourt Ampure XP beads (Beckman Coulter, Cat# A63881) and the final product was reconstituted in 20 µl TE buffer. The concentration of cDNA was measured by Qubit™ 1× dsDNA High Sensitivity (HS) Assay Kit (Invitrogen, Cat# Q33230). Tagmentation and NGS library was carried out by using TruePrep DNA Library Prep Kit V2 for Illumina (Vazyme, Cat# TD503) following the manufacturer's instructions. The purified library was qualify controlled by measuring the fragment size distribution with an Agilent HS DNA BioAnalyzer Chip and the concentration of library was measured with Qubit™ 1× dsDNA High Sensitivity (HS) Assay Kits following the manufacturer's instructions. Single cell cDNA libraries were sequenced on an Illumina HiSeq X Ten platform to obtain paired-end 150-bp reads. SMART-Seq2 (Picelli et al., 2014)
Runs: 1 run, 6M spots, 1.8G bases, 698.6Mb
Run# of Spots# of BasesSizePublished
SRR256873926,037,4621.8G698.6Mb2024-07-01

ID:
28850758

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...